Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset.
Wichgers Schreur PJ, Mooij P, Koopman G, Verstrepen BE, Fagrouch Z, Mortier D, van Driel N, Kant J, van de Water S, Bogers WM, Punt C, van Keulen L, Verschoor EJ, Kortekaas J. Wichgers Schreur PJ, et al. Among authors: mooij p. NPJ Vaccines. 2022 May 18;7(1):54. doi: 10.1038/s41541-022-00476-y. NPJ Vaccines. 2022. PMID: 35585071 Free PMC article.
Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.
Verschoor EJ, Mooij P, Oostermeijer H, van der Kolk M, ten Haaft P, Verstrepen B, Sun Y, Morein B, Akerblom L, Fuller DH, Barnett SW, Heeney JL. Verschoor EJ, et al. Among authors: mooij p. J Virol. 1999 Apr;73(4):3292-300. doi: 10.1128/JVI.73.4.3292-3300.1999. J Virol. 1999. PMID: 10074183 Free PMC article.
HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates.
Heeney J, Akerblom L, Barnett S, Bogers W, Davis D, Fuller D, Koopman G, Lehner T, Mooij P, Morein B, de Giuli Morghen C, Rosenwirth B, Verschoor E, Wagner R, Wolf H. Heeney J, et al. Among authors: mooij p. Immunol Lett. 1999 Mar;66(1-3):189-95. doi: 10.1016/s0165-2478(98)00157-6. Immunol Lett. 1999. PMID: 10203054
Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus.
Verschoor EJ, Davis D, van Gils M, Koopman G, Mooij P, Oostermeijer H, Haaft PT, Verstrepen B, Rosenwirth B, Morein B, Barnett SW, Heeney JL. Verschoor EJ, et al. Among authors: mooij p. J Med Primatol. 1999 Aug-Oct;28(4-5):224-32. doi: 10.1111/j.1600-0684.1999.tb00273.x. J Med Primatol. 1999. PMID: 10593489
72 results